產(chǎn)品屬性：
產(chǎn)品名稱 | Isocorydine |
規(guī)格 | 1mg、5mg、10mg、20mg |
貨號(hào) | EY-01Y21120 |
Cas No.: 475-67-2
別名: N/A
化學(xué)名: N/A
分子式: C20H23NO4
分子量: 341.4
溶解度: Chloroform: 10 mg/ml
儲(chǔ)存條件: 4°C, protect from light
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述：
Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].Isocorydine (0-400 ug/ml; 48 hours) show a significant decrease in the IC50 for ICD and DOX, the CI values are 0.605, 0.644, 0.804, and 0.707 respectively for Huh-7, Hep-G2, SNU-449 and SNU-387[1]. Isocorydine (0-400 ug/ml; 48 hours)abrogates DOX-induced upregulation of mesenchymal markers and the downregulation of epithelial markers in human HCC cell lines[1].Cell Viability Assay[1]Cell Line:Huh-7, Hep-G2 , SNU-387, SNU-449 cellsIsocorydine (intraperitoneal injection; 0.4 mg/kg; every 2 days for 2 weeks) retards the tumor growth, but the combined treatment of Doxorubicin (DOX) or ICD significantly inhibits tumor growth[1].
特別提醒公司產(chǎn)品僅供科研使用
